{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:48:53Z","timestamp":1791557333970,"version":"4.3.4"},"reference-count":50,"publisher":"Japan Atherosclerosis Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2025,4,1]]},"DOI":"10.5551\/jat.65177","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T22:11:39Z","timestamp":1730239899000},"page":"439-457","source":"Crossref","is-referenced-by-count":12,"title":["Inflammatory Biomarkers as Predictors of Symptomatic Venous Thromboembolism in Hospitalized Patients with AECOPD: A Multicenter Cohort Study"],"prefix":"10.5551","volume":"32","author":[{"given":"Jiaxin","family":"Zeng","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Feng","sequence":"additional","affiliation":[{"name":"West China School of Medicine, West China Hospital, Sichuan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanming","family":"Luo","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Disease, Guangzhou Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, People's Hospital of Leshan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiguo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, the First People's Hospital of Neijiang City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinhua","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiuFang","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, the First People's Hospital of Neijiang City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqiu","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Emergency, First People's Hospital of Jiujiang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Emergency, First People's Hospital of Jiujiang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Chengdu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lige","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Pu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University"},{"name":"Sichuan Cancer Hospital, University of Electronic Science and Technology of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the MAGNET AECOPD Registry Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","unstructured":"1) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018; 392: 1736-1788"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Agust\u00ed A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, Bourbeau J, Han MK, Martinez FJ, Montes de Oca M, Mortimer K, Papi A, Pavord I, Roche N, Salvi S, Sin DD, Singh D, Stockley R, L\u00f3pez Varela MV, Wedzicha JA, Vogelmeier CF: Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Am J Respir Crit Care Med, 2023; 207: 819-837","DOI":"10.1164\/rccm.202301-0106PP"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ambrosetti M, Ageno W, Spanevello A, Salerno M, Pedretti RF: Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD. Thromb Res, 2003; 112: 203-207","DOI":"10.1016\/j.thromres.2003.12.003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Keramidas G, Gourgoulianis KI, Kotsiou OS: Venous Thromboembolic Disease in Chronic Inflammatory Lung Diseases: Knowns and Unknowns. J Clin Med, 2021; 10:","DOI":"10.3390\/jcm10102061"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Chen Y, Zhong H, Zhao Y, Luo X, Gao W: Role of platelet biomarkers in inflammatory response. Biomark Res, 2020; 8: 28","DOI":"10.1186\/s40364-020-00207-2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Xue J, Ma D, Jiang J, Liu Y: Diagnostic and Prognostic Value of Immune\/Inflammation Biomarkers for Venous Thromboembolism: Is It Reliable for Clinical Practice? J Inflamm Res, 2021; 14: 5059-5077","DOI":"10.2147\/JIR.S327014"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Otasevic V, Mihaljevic B, Milic N, Stanisavljevic D, Vukovic V, Tomic K, Fareed J, Antic D: Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients. Thromb J, 2022; 20: 20","DOI":"10.1186\/s12959-022-00381-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hojker M, Tr\u0161an J, Tr\u0161an U, Gale A, Jerman A, Ko\u0161uta D: Predictive value of inflammatory and coagulation biomarkers for venous thromboembolism in COVID-19 patients. Clin Hemorheol Microcirc, 2023; 83: 387-395","DOI":"10.3233\/CH-221664"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Maners J, Gill D, Pankratz N, Laffan MA, Wolberg AS, de Maat MPM, Ligthart S, Tang W, Ward-Caviness CK, Fornage M, Debette S, Dichgans M, McKnight B, Boerwinkle E, Smith NL, Morrison AC, Dehghan A, de Vries PS: A Mendelian randomization of \u03b3\u2019 and total fibrinogen levels in relation to venous thromboembolism and ischemic stroke. Blood, 2020; 136: 3062-3069","DOI":"10.1182\/blood.2019004781"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Sheinenzon A, Shehadeh M, Michelis R, Shaoul E, Ronen O: Serum albumin levels and inflammation. Int J Biol Macromol, 2021; 184: 857-862","DOI":"10.1016\/j.ijbiomac.2021.06.140"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Elmoamly S, Mattar M, Yacoub MF, Afif A: Can Biomarkers of Coagulation, Platelet Activation, and Inflammation Predict Venous Thromboembolism in Patients with Haematological Malignancies? Acta Haematol, 2019; 141: 245-253","DOI":"10.1159\/000496914"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Zhou C, Yi Q, Ge H, Wei H, Liu H, Zhang J, Luo Y, Pan P, Zhang J, Peng L, Aili A, Liu Y, Wang M, Tang Y, Wang L, Zhong X, Wang Y, Zhou H: Validation of Risk Assessment Models Predicting Venous Thromboembolism in Inpatients with Acute Exacerbation Of Chronic Obstructive Pulmonary Disease: A Multicenter Cohort Study in China. Thromb Haemost, 2022; 122: 1177-1185","DOI":"10.1055\/a-1693-0063"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Zhang J, Yi Q, Zhou C, Luo Y, Wei H, Ge H, Liu H, Zhang J, Li X, Xie X, Pan P, Yi M, Cheng L, Zhou H, Liu L, Aili A, Liu Y, Peng L, Pu J, Zhou H: Characteristics, treatments, in-hospital and long-term outcomes among inpatients with acute exacerbation of chronic obstructive pulmonary disease in China: sex differences in a large cohort study. BMC Pulm Med, 2024; 24: 125","DOI":"10.1186\/s12890-024-02948-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P: A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost, 2010; 8: 2450-2457","DOI":"10.1111\/j.1538-7836.2010.04044.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Spyropoulos AC, Anderson FA Jr, FitzGerald G, Decousus H, Pini M, Chong BH, Zotz RB, Bergmann JF, Tapson V, Froehlich JB, Monreal M, Merli GJ, Pavanello R, Turpie AGG, Nakamura M, Piovella F, Kakkar AK, Spencer FA; IMPROVE Investigators: Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest, 2011; 140: 706-714","DOI":"10.1378\/chest.10-1944"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Zhai Z, Kan Q, Li W, Qin X, Qu J, Shi Y, Xu R, Xu Y, Zhang Z, Wang C: VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: The Identification of Chinese Hospitalized Patients\u2019 Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study. Chest, 2019; 155: 114-122","DOI":"10.1016\/j.chest.2018.09.020"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Tapson VF, Decousus H, Pini M, Chong BH, Froehlich JB, Monreal M, Spyropoulos AC, Merli GJ, Zotz RB, Bergmann JF, Pavanello R, Turpie AG, Nakamura M, Piovella F, Kakkar AK, Spencer FA, Fitzgerald G, Anderson FA, Jr.: Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest, 2007; 132: 936-945","DOI":"10.1378\/chest.06-2993"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA, Jr.: Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet, 2008; 371: 387-394","DOI":"10.1016\/S0140-6736(08)60202-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Baser O, Liu X, Phatak H, Wang L, Mardekian J, Kawabata H, Petersel D, Hamilton M, Ramacciotti E: Venous thromboembolism prophylaxis and clinical consequences in medically ill patients. Am J Ther, 2013; 20: 132-142","DOI":"10.1097\/MJT.0b013e31826910dd"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Brown RA, Allegra L, Matera MG, Page CP, Cazzola M: Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination. Pulm Pharmacol Ther, 2006; 19: 419-424","DOI":"10.1016\/j.pupt.2006.04.004"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hayssen H, Cires-Drouet R, Englum B, Nguyen P, Sahoo S, Mayorga-Carlin M, Siddiqui T, Turner D, Yesha Y, Sorkin JD, Lal BK: Systematic review of venous thromboembolism risk categories derived from Caprini score. J Vasc Surg Venous Lymphat Disord, 2022; 10: 1401-1409.e1407","DOI":"10.1016\/j.jvsv.2022.05.003"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Couturaud F, Bertoletti L, Pastre J, Roy PM, Le Mao R, Gagnadoux F, Paleiron N, Schmidt J, Sanchez O, De Magalhaes E, Kamara M, Hoffmann C, Bressollette L, Nonent M, Tromeur C, Salaun PY, Barillot S, Gatineau F, Mismetti P, Girard P, Lacut K, Lemari\u00e9 CA, Meyer G, Leroyer C: Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms. JAMA, 2021; 325: 59-68","DOI":"10.1001\/jama.2020.23567"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Hassen MF, Tilouche N, Jaoued O, Elatrous S: Incidence and Impact of Pulmonary Embolism During Severe COPD Exacerbation. Respir Care, 2019; 64: 1531-1536","DOI":"10.4187\/respcare.06661"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Pang H, Wang L, Liu J, Wang S, Yang Y, Yang T, Wang C: The prevalence and risk factors of venous thromboembolism in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease. Clin Respir J, 2018; 12: 2573-2580","DOI":"10.1111\/crj.12959"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Bahloul M, Chaari A, Tounsi A, Baccouche N, Abid H, Chtara K, Ben Hamida C, Ghadhoune H, Dammak H, Chelly H, Bouaziz M: Incidence and impact outcome of pulmonary embolism in critically ill patients with severe exacerbation of chronic obstructive pulmonary diseases. Clin Respir J, 2015; 9: 270-277","DOI":"10.1111\/crj.12131"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Akpinar EE, Ho\u015fg\u00fcn D, Akpinar S, Ata\u00e7 GK, Do\u011fanay B, G\u00fclhan M: Incidence of pulmonary embolism during COPD exacerbation. J Bras Pneumol, 2014; 40: 38-45","DOI":"10.1590\/S1806-37132014000100006"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Dentali F, Pomero F, Micco PD, La Regina M, Landini F, Mumoli N, Pieralli F, Giorgi-Pierfranceschi M, Re R, Vitale J, Fabbri LM, Fontanella A, Arioli D: Prevalence and risk factors for pulmonary embolism in patients with suspected acute exacerbation of COPD: a multi-center study. Eur J Intern Med, 2020; 80: 54-59","DOI":"10.1016\/j.ejim.2020.05.006"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Choi KJ, Cha SI, Shin KM, Lee J, Hwangbo Y, Yoo SS, Lee J, Lee SY, Kim CH, Park JY, Jung TH: Prevalence and predictors of pulmonary embolism in Korean patients with exacerbation of chronic obstructive pulmonary disease. Respiration, 2013; 85: 203-209","DOI":"10.1159\/000335904"},{"key":"29","unstructured":"29) Risti\u0107 L, Ran\u010di\u0107 M, Radovi\u0107 M, Ciri\u0107 Z, Kutle\u0161i\u0107 Kurtovi\u0107 D: Pulmonary embolism in chronic hypoxemic patients with and without secondary polycythemia--analysis of risk factors in prospective clinical study. Med Glas (Zenica), 2013; 10: 258-265"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Lederle FA, Zylla D, MacDonald R, Wilt TJ: Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med, 2011; 155: 602-615","DOI":"10.7326\/0003-4819-155-9-201111010-00008"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Grant PJ, Greene MT, Chopra V, Bernstein SJ, Hofer TP, Flanders SA: Assessing the Caprini Score for Risk Assessment of Venous Thromboembolism in Hospitalized Medical Patients. Am J Med, 2016; 129: 528-535","DOI":"10.1016\/j.amjmed.2015.10.027"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Rothberg MB, Lindenauer PK, Lahti M, Pekow PS, Selker HP: Risk factor model to predict venous thromboembolism in hospitalized medical patients. J Hosp Med, 2011; 6: 202-209","DOI":"10.1002\/jhm.888"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Liu X, Jiao X, Gong X, Nie Q, Li Y, Zhen G, Cheng M, He J, Yuan Y, Yang Y: Prevalence, Risk Factor and Clinical Characteristics of Venous Thrombus Embolism in Patients with Acute Exacerbation of COPD: A Prospective Multicenter Study. Int J Chron Obstruct Pulmon Dis, 2023; 18: 907-917","DOI":"10.2147\/COPD.S410954"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Righini M: Is it worth diagnosing and treating distal deep vein thrombosis? No. J Thromb Haemost, 2007; 5 Suppl 1: 55-59","DOI":"10.1111\/j.1538-7836.2007.02468.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Kerr R, Stirling D, Ludlam CA: Interleukin 6 and haemostasis. Br J Haematol, 2001; 115: 3-12","DOI":"10.1046\/j.1365-2141.2001.03061.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Tichelaar YI, Kluin-Nelemans HJ, Meijer K: Infections and inflammatory diseases as risk factors for venous thrombosis. A systematic review. Thromb Haemost, 2012; 107: 827-837","DOI":"10.1160\/TH11-09-0611"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Pfeiler S, Stark K, Massberg S, Engelmann B: Propagation of thrombosis by neutrophils and extracellular nucleosome networks. Haematologica, 2017; 102: 206-213","DOI":"10.3324\/haematol.2016.142471"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Hu J, Cai Z, Zhou Y: The Association of Neutrophil-Lymphocyte Ratio with Venous Thromboembolism: A Systematic Review and Meta-Analysis. Clin Appl Thromb Hemost, 2022; 28: 10760296221130061","DOI":"10.1177\/10760296221130061"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Liu H, Guo N, Zheng Q, Zhang Q, Chen J, Cai Y, Luo Q, Xu Q, Chen X, Yang S, Zhang S: Association of interleukin-6, ferritin, and lactate dehydrogenase with venous thromboembolism in COVID-19: a systematic review and meta-analysis. BMC Infect Dis, 2024; 24: 324","DOI":"10.1186\/s12879-024-09205-3"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Li D, Wu Q, Liu S, Chen Y, Chen H, Ruan Y, Zhang Y: Lactic Dehydrogenase in the In Vitro Evaluation of Hemolytic Properties of Ventricular Assist Device. Artif Organs, 2017; 41: E274-e284","DOI":"10.1111\/aor.12943"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) McFadyen JD, Kiefer J, Braig D, Loseff-Silver J, Potempa LA, Eisenhardt SU, Peter K: Dissociation of C-Reactive Protein Localizes and Amplifies Inflammation: Evidence for a Direct Biological Role of C-Reactive Protein and Its Conformational Changes. Front Immunol, 2018; 9: 1351","DOI":"10.3389\/fimmu.2018.01351"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Heerink JS, Gemen E, Oudega R, Geersing GJ, Hopstaken R, Kusters R: Performance of C-Reactive Protein, Procalcitonin, TAT Complex, and Factor VIII in Addition to D-Dimer in the Exclusion of Venous Thromboembolism in Primary Care Patients. J Appl Lab Med, 2022; 7: 444-455","DOI":"10.1093\/jalm\/jfab094"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Liu Y, Meng X, Feng J, Zhou X, Zhu H: Hypereosinophilia with Concurrent Venous Thromboembolism: Clinical Features, Potential Risk Factors, and Short-term Outcomes in a Chinese Cohort. Sci Rep, 2020; 10: 8359","DOI":"10.1038\/s41598-020-65128-4"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Wypasek E, Padjas A, Szyma\u0144ska M, Plens K, Siedlar M, Undas A: Non-classical and intermediate monocytes in patients following venous thromboembolism: Links with inflammation. Adv Clin Exp Med, 2019; 28: 51-58","DOI":"10.17219\/acem\/76262"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Xu WJ, Wang S, Yuan P, Wang L, Huang JX, Jiang R: Arterial and venous thromboembolism risk associated with blood eosinophils: A systematic review and meta-analysis. Animal Model Exp Med, 2022; 5: 470-481","DOI":"10.1002\/ame2.12277"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Pu J, Yi Q, Luo Y, Wei H, Ge H, Liu H, Li X, Zhang J, Pan P, Zhou H, Zhou C, Yi M, Cheng L, Liu L, Zhang J, Peng L, Aili A, Liu Y, Zhou H: Blood Eosinophils and Clinical Outcomes in Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study. Int J Chron Obstruct Pulmon Dis, 2023; 18: 169-179","DOI":"10.2147\/COPD.S396311"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Wan MX, Zhang XW, T\u00f6rkvist L, Thorlacius H: Low molecular weight heparin inhibits tumor necrosis factor alpha-induced leukocyte rolling. Inflamm Res, 2001; 50: 581-584","DOI":"10.1007\/PL00000237"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Feng K, Wang K, Zhou Y, Xue H, Wang F, Jin H, Zhao W: Non-Anticoagulant Activities of Low Molecular Weight Heparins-A Review. Pharmaceuticals (Basel), 2023; 16:","DOI":"10.3390\/ph16091254"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein RC, Le H, Schulman S, Murad MH: Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012; 141: e195S-e226S","DOI":"10.1378\/chest.11-2296"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Thachil J, Favaloro EJ, Lippi G: D-dimers-"Normal" Levels versus Elevated Levels Due to a Range of Conditions, including "D-dimeritis," Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19. Semin Thromb Hemost, 2022; 48: 672-679","DOI":"10.1055\/s-0042-1748193"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/4\/32_65177\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:40:25Z","timestamp":1743828025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/4\/32_65177\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65177","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"article-number":"65177"}}